Search
for

    Sort by

    Research 61–90 of 1000+

    1. Genetic and molecular aspects of androgenetic alopecia Indian Journal of Dermatology, Venereology and Leprology · 2018 · 24 citations
    2. Characterization of metabolic changes in the phenotypes of women with polycystic ovary syndrome in a large Mediterranean population from Sicily Clinical Endocrinology · 2019 · 18 citations
    3. Polycystic ovary syndrome in men Medical Hypotheses · 2017 · 8 citations
    4. Urinary 5-ene-steroid excretion in non-classical congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency (NC-3BHSD) Journal of Steroid Biochemistry · 1990 · 3 citations
    5. Bicalutamide: A review Journal of Cutaneous and Aesthetic Surgery · 2024
    6. Comparison of Components of Metabolic Syndrome in Androgenic Alopecia versus Healthy Population 2019
    7. A quantitative ultra-performance liquid chromatography high-resolution mass spectrometry analysis of steroids from human scalp hair Journal of pharmaceutical and biomedical analysis · 2022 · 7 citations
    8. Dyslipidemia in patients with androgenetic alopecia. Statins, finasteride or both? Journal of The European Academy of Dermatology and Venereology · 2017
    9. Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference? Nutrition in Clinical Practice · 2008 · 48 citations
    10. Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia Figshare · 2026
    11. Salivary Inflammatory Markers and Free Androgen Index in Women with Polycystic Ovary Syndrome: A Case-Control Study Journal of Obstetrics Gynecology and Cancer Research · 2026
    12. Androgen Secreting Steroid Cell Tumor of the Ovary Represented with Postmenopasal Bleeding and Extensive Hirsutism Macedonian Journal of Medical Sciences · 2013
    13. Novel Dual Soft Drug Strategy Enables Development of Topical Androgen Receptor Antagonists with Enhanced Efficacy and Optimized Safety for Androgenetic Alopecia Journal of Medicinal Chemistry · 2026
    14. Comparative transcriptome profiling provides new insights into mechanisms of androgenetic alopecia progression British Journal of Dermatology · 2016 · 12 citations
    15. Sertoli–Leydig cell tumors: hormonal profile after dynamic test with GnRH analogue: triptorelin represents a useful tool to evaluate tumoral hyperandrogenism Gynecological Endocrinology · 2014 · 5 citations
    16. Serum androgens and prostate-specific antigen levels in androgenetic alopecia: is there a difference between frontal and vertex baldness? Journal of The European Academy of Dermatology and Venereology · 2017 · 1 citations
    17. Amazonian peppers as new ingredients against male androgen alopecia Zenodo (CERN European Organization for Nuclear Research) · 2022
    18. Distribution of Cu, Mn, Se and Zn in occipital and frontal hair zones and hormonal profiles in women with androgenetic alopecia Surgery · 2013
    19. Effect of resveratrol on menstrual cyclicity, hyperandrogenism and metabolic profile in women with PCOS Clinical Nutrition · 2021 · 36 citations
    20. Arrhythmia phenotypes in hair-loss therapies: insights from minoxidil and finasteride reports in eudravigilance EP Europace · 2026
    21. 211 TRIGLYCERIDEMIA IN CONDITION OF FOOD STRESS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME AND ANDROGENIC ALOPECIA Reproductive Biomedicine Online · 2010
    22. Serum Metabolomics Study of Polycystic Ovary Syndrome Based on Liquid Chromatography–Mass Spectrometry Journal of Proteome Research · 2014 · 71 citations
    23. The role of inflammation and immunity in the pathogenesis of androgenetic alopecia. PubMed · 2011 · 19 citations
    24. Histopathologycal and topical immunologycal changes in alopeciae Journal of the European Academy of Dermatology and Venereology · 1998
    25. Dyslipidaemia in women with polycystic ovary syndrome referred to a teaching hospital in Cape Town, South Africa Journal of Neuroendocrinology · 2024 · 3 citations
    26. Rotterdam criteria–based diagnostic subtype is not a strong predictor of cutaneous phenotype in patients with polycystic ovary syndrome: A cross-sectional study Journal of The American Academy of Dermatology · 2017 · 2 citations
    27. Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weight Clinical Endocrinology · 2011 · 28 citations
    28. Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome? PubMed · 2005 · 12 citations
    29. The Hormonal Background of Hair Loss in Non-Scarring Alopecias Biomedicines · 2024
    30. Anogenital distance as a biomarker for incomplete masculinization : Molecular mechanisms in the perineum Research Portal Denmark · 2020